Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,502 | 48 | 80.2% |
| Education | $369.92 | 4 | 19.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $544.36 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $426.24 | 7 | $0 (2022) |
| Amgen Inc. | $194.89 | 4 | $0 (2022) |
| Merz North America, Inc. | $134.23 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $109.24 | 6 | $0 (2022) |
| Genentech USA, Inc. | $105.11 | 5 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $95.24 | 4 | $0 (2022) |
| GENZYME CORPORATION | $86.77 | 4 | $0 (2022) |
| Helsinn Therapeutics (U.S.), Inc. | $31.83 | 2 | $0 (2022) |
| LEO Pharma Inc. | $29.91 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.17 | 1 | ABBVIE INC. ($15.17) |
| 2022 | $867.05 | 19 | ABBVIE INC. ($357.48) |
| 2021 | $221.13 | 7 | Janssen Biotech, Inc. ($99.99) |
| 2020 | $369.40 | 11 | Amgen Inc. ($141.97) |
| 2019 | $332.26 | 11 | Janssen Biotech, Inc. ($121.87) |
| 2018 | $66.52 | 3 | Genentech USA, Inc. ($41.62) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: IMMUNOLOGY | ||||||
| 06/10/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Immunology | ||||||
| 06/03/2022 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 06/03/2022 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: ONCOLOGY | ||||||
| 05/27/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Immunology | ||||||
| 05/24/2022 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Immunology | ||||||
| 05/12/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $120.42 | General |
| 05/06/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Immunology | ||||||
| 04/29/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Inflammation | ||||||
| 04/15/2022 | Sun Pharmaceutical Industries Inc. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Oncology | ||||||
| 04/01/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $117.97 | General |
| Category: IMMUNOLOGY | ||||||
| 02/18/2022 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: BioOncology | ||||||
| 02/11/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: DERMATOLOGY | ||||||
| 02/04/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: IMMUNOLOGY | ||||||
| 01/21/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Dermatology | ||||||
| 01/21/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $18.37 | General |
| Category: Dermatology | ||||||
| 01/19/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $96.14 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2022 | Merz North America, Inc. | Xeomin | Food and Beverage | In-kind items and services | $134.23 | General |
| 12/03/2021 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Inflammation | ||||||
| 08/13/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2021 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: BioOncology | ||||||
| 06/11/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $16.79 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,392 | 2,408 | $380,823 | $93,387 |
| 2022 | 8 | 292 | 423 | $73,585 | $20,140 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 236 | 276 | $60,095 | $17,704 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 199 | 199 | $59,153 | $13,425 | 22.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 262 | 324 | $61,074 | $12,515 | 20.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 135 | 147 | $43,108 | $10,481 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 122 | $37,661 | $10,064 | 26.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 114 | 128 | $41,984 | $9,834 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 71 | 71 | $31,986 | $7,526 | 23.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 201 | 1,054 | $18,709 | $5,189 | 27.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 28 | 32 | $14,659 | $3,626 | 24.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 18 | $6,642 | $1,587 | 23.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 31 | 37 | $5,754 | $1,436 | 25.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 62 | 62 | $17,903 | $4,940 | 27.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 46 | 48 | $13,668 | $3,678 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $12,243 | $3,182 | 26.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 53 | 60 | $11,835 | $2,646 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 27 | $5,771 | $1,943 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 18 | $5,445 | $1,727 | 31.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 12 | 12 | $3,822 | $1,102 | 28.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 47 | 168 | $2,898 | $922.02 | 31.8% |
About Dr. Lucy Chao, MD
Dr. Lucy Chao, MD is a Dermatology healthcare provider based in Everett, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1396136057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lucy Chao, MD has received a total of $1,872 in payments from pharmaceutical and medical device companies, with $15.17 received in 2024. These payments were reported across 52 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,502).
As a Medicare-enrolled provider, Chao has provided services to 1,684 Medicare beneficiaries, totaling 2,831 services with total Medicare billing of $113,527. Data is available for 2 years (2022–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Everett, WA
- Active Since 02/16/2015
- Last Updated 09/17/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1396136057
Products in Payments
- TREMFYA (Drug) $304.37
- RINVOQ (Biological) $237.06
- Otezla (Drug) $177.73
- COSENTYX (Biological) $109.24
- Tremfya (Drug) $99.99
- Skyrizi (Biological) $83.07
- Erivedge (Biological) $63.49
- SKYRIZI (Biological) $51.85
- DUPIXENT (Biological) $49.81
- ILUMYA (Biological) $49.45
- DUPIXENT (Drug) $36.96
- VALCHLOR (Drug) $31.83
- VENCLEXTA (Biological) $30.17
- ADBRY (Biological) $29.91
- Lonsurf (Drug) $24.90
- Ilumya (Biological) $23.35
- Odomzo (Drug) $22.44
- REMICADE (Biological) $21.88
- Humira (Biological) $18.11
- TALTZ (Drug) $17.30
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Everett
Sarah Hocker
Dermatology — Payments: $7,912
Dr. Susan Oldenkamp, M.d, M.D
Dermatology — Payments: $3,382
Dr. Mark Valentine, M.d, M.D
Dermatology — Payments: $3,005
Hana Stelle, M.d, M.D
Dermatology — Payments: $1,634
Dr. Teerawit Supakorndej, Md, MD
Dermatology — Payments: $688.13
Dr. Zarry Tavakkol, M.d, M.D
Dermatology — Payments: $165.03